FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W963173703> ?p ?o ?g. }

• W963173703 endingPage "251" @default.
• W963173703 startingPage "245" @default.
• W963173703 abstract "It remains unknown whether dipeptidyl peptidase-4 (DPP-4) inhibitors improve early-phase insulin secretion in Japanese patients with type 2 diabetes (T2D), a disease characterized by impaired insulin secretion. We investigated the changes in insulin secretion before and after treatment with the DPP-4 inhibitor teneligliptin in patients with T2D with a low insulinogenic index (IGI) determined by the oral glucose tolerance test (OGTT). An open-label, prospective clinical study was conducted. Thirteen drug-naïve patients (mean age 55.5 ± 3.9 years) with T2D underwent OGTT before and after teneligliptin 20 mg/day monotherapy. Plasma levels of glucose (PG), insulin, and C-peptide were measured at 0, 30, 60, 90, and 120 min after glucose loading in the OGTT. Homeostasis model assessment (HOMA)-β, IGI, and the total or incremental area under the curve (AUC) for PG and insulin were measured. AUC120min for the secretory units of islets in transplantation (SUIT) index was also measured. HbA1c significantly decreased from 8.3 ± 0.4 % at baseline to 6.3 ± 0.2 % after 12 weeks of teneligliptin treatment (p < 0.05). Incremental AUC120min PG also significantly decreased, and β-cell function assessed by IGI30min, AUC120min insulin, and the AUC120min SUIT index significantly increased (0.16 ± 0.05 vs. 0.28 ± 0.06, 2692 ± 333 µU·2h/mL vs. 3537 ± 361 µU·2h/mL, and 4261 ± 442 vs. 8290 ± 1147, respectively; all p < 0.05). HOMA-β was unchanged. The reduction in incremental AUC120min PG was significantly associated with the augmentation of IGI30min and the AUC120min SUIT index. No severe adverse events were observed. Twelve weeks of teneligliptin treatment improved IGI30min, AUC120min, and the SUIT index in drug-naïve Japanese patients with T2D." @default.
• W963173703 created "2016-06-24" @default.
• W963173703 creator A5009535492 @default.
• W963173703 creator A5035678112 @default.
• W963173703 creator A5037548640 @default.
• W963173703 creator A5049162246 @default.
• W963173703 creator A5054538535 @default.
• W963173703 creator A5056403336 @default.
• W963173703 creator A5057203723 @default.
• W963173703 creator A5073711245 @default.
• W963173703 creator A5085280950 @default.
• W963173703 date "2015-07-30" @default.
• W963173703 modified "2023-10-16" @default.
• W963173703 title "Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor, Improves Early-Phase Insulin Secretion in Drug-Naïve Patients with Type 2 Diabetes" @default.
• W963173703 cites W1576760610 @default.
• W963173703 cites W1969932276 @default.
• W963173703 cites W1971593735 @default.
• W963173703 cites W1983286754 @default.
• W963173703 cites W2002668094 @default.
• W963173703 cites W2015017251 @default.
• W963173703 cites W2026669955 @default.
• W963173703 cites W2027518448 @default.
• W963173703 cites W2028212562 @default.
• W963173703 cites W2036167841 @default.
• W963173703 cites W2038445107 @default.
• W963173703 cites W2056182647 @default.
• W963173703 cites W2056526409 @default.
• W963173703 cites W2058885439 @default.
• W963173703 cites W2089304685 @default.
• W963173703 cites W2097395605 @default.
• W963173703 cites W2116230803 @default.
• W963173703 cites W2124020657 @default.
• W963173703 cites W2160234571 @default.
• W963173703 cites W2161399472 @default.
• W963173703 cites W2161483908 @default.
• W963173703 cites W2172089659 @default.
• W963173703 cites W2607031541 @default.
• W963173703 doi "https://doi.org/10.1007/s40268-015-0096-6" @default.
• W963173703 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4561050" @default.
• W963173703 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26224337" @default.
• W963173703 hasPublicationYear "2015" @default.
• W963173703 type Work @default.
• W963173703 sameAs 963173703 @default.
• W963173703 citedByCount "9" @default.
• W963173703 countsByYear W9631737032015 @default.
• W963173703 countsByYear W9631737032016 @default.
• W963173703 countsByYear W9631737032017 @default.
• W963173703 countsByYear W9631737032018 @default.
• W963173703 countsByYear W9631737032020 @default.
• W963173703 crossrefType "journal-article" @default.
• W963173703 hasAuthorship W963173703A5009535492 @default.
• W963173703 hasAuthorship W963173703A5035678112 @default.
• W963173703 hasAuthorship W963173703A5037548640 @default.
• W963173703 hasAuthorship W963173703A5049162246 @default.
• W963173703 hasAuthorship W963173703A5054538535 @default.
• W963173703 hasAuthorship W963173703A5056403336 @default.
• W963173703 hasAuthorship W963173703A5057203723 @default.
• W963173703 hasAuthorship W963173703A5073711245 @default.
• W963173703 hasAuthorship W963173703A5085280950 @default.
• W963173703 hasBestOaLocation W9631737031 @default.
• W963173703 hasConcept C126322002 @default.
• W963173703 hasConcept C134018914 @default.
• W963173703 hasConcept C165220095 @default.
• W963173703 hasConcept C181199279 @default.
• W963173703 hasConcept C185592680 @default.
• W963173703 hasConcept C2777180221 @default.
• W963173703 hasConcept C2777391703 @default.
• W963173703 hasConcept C2778763485 @default.
• W963173703 hasConcept C2779306644 @default.
• W963173703 hasConcept C2781469919 @default.
• W963173703 hasConcept C3018667095 @default.
• W963173703 hasConcept C55493867 @default.
• W963173703 hasConcept C555293320 @default.
• W963173703 hasConcept C71924100 @default.
• W963173703 hasConcept C98274493 @default.
• W963173703 hasConceptScore W963173703C126322002 @default.
• W963173703 hasConceptScore W963173703C134018914 @default.
• W963173703 hasConceptScore W963173703C165220095 @default.
• W963173703 hasConceptScore W963173703C181199279 @default.
• W963173703 hasConceptScore W963173703C185592680 @default.
• W963173703 hasConceptScore W963173703C2777180221 @default.
• W963173703 hasConceptScore W963173703C2777391703 @default.
• W963173703 hasConceptScore W963173703C2778763485 @default.
• W963173703 hasConceptScore W963173703C2779306644 @default.
• W963173703 hasConceptScore W963173703C2781469919 @default.
• W963173703 hasConceptScore W963173703C3018667095 @default.
• W963173703 hasConceptScore W963173703C55493867 @default.
• W963173703 hasConceptScore W963173703C555293320 @default.
• W963173703 hasConceptScore W963173703C71924100 @default.
• W963173703 hasConceptScore W963173703C98274493 @default.
• W963173703 hasIssue "3" @default.
• W963173703 hasLocation W9631737031 @default.
• W963173703 hasLocation W9631737032 @default.
• W963173703 hasLocation W9631737033 @default.
• W963173703 hasLocation W9631737034 @default.
• W963173703 hasOpenAccess W963173703 @default.
• W963173703 hasPrimaryLocation W9631737031 @default.
• W963173703 hasRelatedWork W1850629359 @default.

• next